Clinical pharmacokinetics of meloxicam

Arzneimittel-Forschung/Drug Research

Volumn 47, Issue 3, 1997, Pages 253-258

  Türck, Dietrich ^a   Busch, Ulrich ^a   Heinzel, Günther ^a   Narjes, Hans ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

anti inflammatories, non steroidal; CAS 71125 38 7; meloxicam; UH AC 62 XX, clinical pharmacokinetics

Indexed keywords

MELOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT; UH AC 62XX; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIOAVAILABILITY; BIOEQUIVALENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EXCRETION; DRUG FECES LEVEL; DRUG URINE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; RECTAL DRUG ADMINISTRATION;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CAPSULES; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; HALF-LIFE; HUMANS; MALE; MIDDLE AGED; TABLETS; THERAPEUTIC EQUIVALENCY; THIAZINES; THIAZOLES;

EID: 0030959862     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Engelhardt, G., Homma, D., Schlegel, K. et al., Inflamm. Res. 44, 423 (1995)
2. DeWitt, D. L., Meade, E. S., Smith, W. L., Am. J. Med. 95, Suppl. 2A, 40 (1993)
3. Engelhardt, G., Bögel, R., Schnitzler, C. H. R. et al., Biochem. Pharmacol. 51, 21 (1996)
4. Churchill, L., Graham, A. G., Shih, C.-K. et al., Inflammopharmacology 4, 125 (1996)
5. Pairet, M., Engelhardt, G., in: Improved non-steroid anti-inflammatory drugs - COX-2 enzyme inhibitors, J. Vane, J. Botting, R. Botting (eds.), pp. 85-102, Kluwer Academic Publishers, London (1996)
6. Türck, D., Roth, W., Busch, U., Br. J. Rheumatol. 35 (Suppl. 1), 13 (1996)
7. Crevoisier, C, Heizmann, P., Forge, I. et al., Eur. J. Drug. Metab. Pharmacol. 9, 23 (1989)
8. Nilsen, O. G., Clin. Pharmacokinet. 26, 16 (1994)
9. Hobbs, D. C., Twomey, T. M., J. Clin. Pharmacol. 19, 240 (1979)
10. Verbeeck, R. K., Richardson, C. J., Blocka, K. L. N., J. Rheumatol. 13, 789 (1986)
11. Busch, U., Heinzel, G., Narjes, H., Eur. J. Clin. Pharmacol. 48, 269 (1995)
12. Shah, V., Midha, K. K., Dighe, S. et al., Pharm. Res. 9, 588 (1992)
13. Heinzel, G., Woloszczak, R., Thomann, P., in: TopFit, a pharmacokinetic pharmacodynamic data fitting program. (Version 2.0), G. Fischer (ed.), Stuttgart-Jena etc. (1991)
14. Gibaldi, M., in: Biopharmaceutics and Clinical Pharmacokinetics, 4th edition, Lea & Febiger, Philadelphia-London (1991)
15. Schuirman, D. J. J. Pharmacokinet. biopharm. 15, 657 (1992)
16. Hauschke, D., Steinijans, V. W., Diletti, E. Int. J. Clin. Pharmacol. Ther. Toxicol. 28, 72 (1990)
17. Ghozlan, P. R., Bernhardt, M., Vélicitat, P. et al., Br. J. Rheumatol. 35 (Suppl. 1), 51 (1996)
18. Busch, U., Schmid, J., Clin. Exp. Rheumatol. 5 (Suppl. 2), 145 (1987)
19. Busch, U., Engelhardt, G., Drugs Exp. Clin. Res. 16, 49 (1990)